SCILEX HOLDING COMPANY |
Market Closed -
Nasdaq
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.090 USD | -5.22% |
|
+6.86% | -46.57% |
| 09-12 | Scilex Gets Drug Distributor Accreditation from National Association of Boards of Pharmacy | MT |
| 09-03 | Scilex Unit Semnur Pharmaceuticals, Denali Capital Sign Merger Agreement | MT |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
Revenues | 21.03M | 23.56M | 31.32M | 38.03M | 46.74M |
Total Revenues | 21.03M | 23.56M | 31.32M | 38.03M | 46.74M |
Cost of Goods Sold, Total | 5.8M | 2.15M | 3.63M | 10.8M | 15.68M |
Gross Profit | 15.23M | 21.41M | 27.68M | 27.24M | 31.06M |
Selling General & Admin Expenses, Total | 64.7M | 42.97M | 50.58M | 64.9M | 120M |
R&D Expenses | 10.22M | 9.96M | 9.2M | 9.05M | 12.75M |
Amortization of Goodwill and Intangible Assets - (IS) | 3.71M | 3.74M | 3.74M | 3.92M | 4.11M |
Other Operating Expenses, Total | 78.62M | 56.67M | 63.52M | 77.87M | 136M |
Operating Income | -63.39M | -35.26M | -35.84M | -50.63M | -105M |
Interest Expense, Total | -16.89M | -13.12M | -11.76M | -9.6M | -1.07M |
Interest And Investment Income | 460K | - | - | - | - |
Net Interest Expenses | -16.43M | -13.12M | -11.76M | -9.6M | -1.07M |
Currency Exchange Gains (Loss) | -168K | 2K | -54K | -66K | -118K |
Other Non Operating Income (Expenses) | -23.3M | 800K | -28.3M | 8.31M | -512K |
EBT, Excl. Unusual Items | -103M | -47.57M | -75.96M | -51.99M | -107M |
In Process R&D Expenses | -75.3M | - | - | - | - |
Other Unusual Items | - | - | -12.46M | 28.63M | -7.19M |
EBT, Incl. Unusual Items | -179M | -47.57M | -88.42M | -23.36M | -114M |
Income Tax Expense | 2K | -53K | 5K | 4K | 13K |
Earnings From Continuing Operations | -179M | -47.52M | -88.42M | -23.36M | -114M |
Net Income to Company | -179M | -47.52M | -88.42M | -23.36M | -114M |
Net Income - (IS) | -179M | -47.52M | -88.42M | -23.36M | -114M |
Preferred Dividend and Other Adjustments | - | - | - | - | 52.64M |
Net Income to Common Incl Extra Items | -179M | -47.52M | -88.42M | -23.36M | -167M |
Net Income to Common Excl. Extra Items | -179M | -47.52M | -88.42M | -23.36M | -167M |
Per Share Items | |||||
Net EPS - Basic | -0.95 | -0.24 | -0.45 | -0.17 | -1.28 |
Basic EPS - Continuing Operations | -0.95 | -0.24 | -0.45 | -0.17 | -1.28 |
Basic Weighted Average Shares Outstanding | 188M | 197M | 197M | 134M | 130M |
Net EPS - Diluted | -0.95 | -0.24 | -0.45 | -0.17 | -1.28 |
Diluted EPS - Continuing Operations | -0.95 | -0.24 | -0.45 | -0.17 | -1.28 |
Diluted Weighted Average Shares Outstanding | 188M | 197M | 197M | 134M | 130M |
Normalized Basic EPS | -0.34 | -0.15 | -0.24 | -0.24 | -0.51 |
Normalized Diluted EPS | -0.34 | -0.15 | -0.24 | -0.24 | -0.51 |
Supplemental Items | |||||
EBITDA | -59.64M | -31.48M | -32.06M | -46.67M | -101M |
EBITA | -59.68M | -31.52M | -32.1M | -46.71M | -101M |
EBIT | -63.39M | -35.26M | -35.84M | -50.63M | -105M |
EBITDAR | -58.87M | -30.58M | -31.44M | -46.2M | -100M |
Effective Tax Rate - (Ratio) | -0 | 0.11 | -0.01 | -0.02 | -0.01 |
Current Domestic Taxes | 2K | -53K | 5K | 4K | 13K |
Total Current Taxes | 2K | -53K | 5K | 4K | 13K |
Deferred Domestic Taxes | - | - | - | 0 | 0 |
Total Deferred Taxes | - | - | - | 0 | 0 |
Normalized Net Income | -64.56M | -29.73M | -47.47M | -32.5M | -66.96M |
Interest on Long-Term Debt | - | - | - | - | 4.4M |
Supplemental Operating Expense Items | |||||
Research And Development Expense From Footnotes | 85.52M | 9.96M | 9.2M | 9.05M | 12.75M |
Net Rental Expense, Total | 776K | 904K | 623K | 469K | 1.1M |
Imputed Operating Lease Interest Expense | - | - | 400K | 462K | 145K |
Imputed Operating Lease Depreciation | - | - | 223K | 7.48K | 955K |
Stock-Based Comp., Other (Total) | 4.33M | 5.4M | 5.82M | 5.28M | 14.6M |
Total Stock-Based Compensation | 4.33M | 5.4M | 5.82M | 5.28M | 14.6M |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
Assets | |||||
Cash And Equivalents | - | 4.84M | 4.34M | 2.18M | 3.92M |
Total Cash And Short Term Investments | - | 4.84M | 4.34M | 2.18M | 3.92M |
Accounts Receivable, Total | - | 13.13M | 14.27M | 21.24M | 34.6M |
Total Receivables | - | 13.13M | 14.27M | 21.24M | 34.6M |
Inventory | - | 1.14M | 2.56M | 1.38M | 4.21M |
Prepaid Expenses | - | 3.31M | 1.84M | 4.81M | 4.05M |
Total Current Assets | - | 22.42M | 23M | 29.61M | 46.78M |
Gross Property Plant And Equipment | - | 2.61M | 2.24M | 2.07M | 3.72M |
Accumulated Depreciation | - | -88K | -127K | -167K | -58K |
Net Property Plant And Equipment | - | 2.52M | 2.11M | 1.9M | 3.66M |
Goodwill | - | 13.48M | 13.48M | 13.48M | 13.48M |
Other Intangibles, Total | - | 42.54M | 38.8M | 40.59M | 36.48M |
Other Long-Term Assets, Total | - | 538K | 538K | 944K | 897K |
Total Assets | - | 81.5M | 77.93M | 86.53M | 101M |
Liabilities | |||||
Accounts Payable, Total | - | 8.12M | 4.28M | 8.45M | 40.95M |
Accrued Expenses, Total | - | 14.38M | 14.35M | 35.38M | 99.75M |
Short-term Borrowings | - | 13.01M | 19.61M | - | - |
Current Portion of Long-Term Debt | - | 15.89M | 37.95M | - | 108M |
Current Portion of Leases | - | 424K | 500K | 745K | 759K |
Other Current Liabilities | - | 26.66M | 92.72M | 264K | 491K |
Total Current Liabilities | - | 78.48M | 169M | 44.84M | 250M |
Long-Term Debt | - | 108M | 95.54M | - | 17.04M |
Long-Term Leases | - | 1.65M | 1.15M | 665K | 2.24M |
Other Non Current Liabilities | - | 35.4M | 35.7M | 4.78M | 4.59M |
Total Liabilities | - | 223M | 302M | 50.29M | 274M |
Preferred Stock Convertible | - | - | - | 3K | - |
Total Preferred Equity | - | - | - | 3K | - |
Common Stock, Total | - | 20K | 20K | 14K | 16K |
Additional Paid In Capital | - | 122M | 129M | 412M | 408M |
Retained Earnings | - | -264M | -353M | -376M | -490M |
Treasury Stock | - | - | - | - | -90.52M |
Total Common Equity | - | -142M | -224M | 36.24M | -173M |
Total Equity | - | -142M | -224M | 36.24M | -173M |
Total Liabilities And Equity | - | 81.5M | 77.93M | 86.53M | 101M |
Supplemental Items | |||||
ECS Total Shares Outstanding on Filing Date | 188M | 197M | 197M | 146M | 106M |
ECS Total Common Shares Outstanding | 188M | 197M | 197M | 141M | 100M |
Book Value / Share | - | -0.72 | -1.13 | 0.26 | -1.73 |
Tangible Book Value | - | -198M | -276M | -17.84M | -223M |
Tangible Book Value Per Share | - | -1 | -1.4 | -0.13 | -2.23 |
Total Debt | - | 139M | 155M | 1.41M | 128M |
Net Debt | - | 134M | 150M | -774K | 125M |
Debt Equivalent Oper. Leases | 6.21M | 7.23M | 4.98M | 3.75M | 8.8M |
Account Code - Inventory Valuation | - | - | 5 | 5 | 5 |
Machinery, Total | - | 195K | 195K | 195K | 41K |
Full Time Employees | - | - | 76 | 90 | 105 |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
Net Income | -179M | -47.52M | -88.42M | -23.36M | -114M |
Depreciation & Amortization - CF | 37K | 39K | 41K | 39K | 40K |
Amortization of Goodwill and Intangible Assets - (CF) | 3.71M | 3.74M | 3.74M | 3.92M | 4.11M |
Depreciation & Amortization, Total | 3.75M | 3.78M | 3.78M | 3.96M | 4.15M |
Amortization of Deferred Charges, Total - (CF) | 15.03M | 10.66M | 7.91M | 3.14M | 65K |
Stock-Based Compensation (CF) | 4.33M | 5.4M | 5.82M | 5.28M | 14.6M |
Other Operating Activities, Total | 99.13M | -10.84M | 28.65M | -55.94M | 9.02M |
Change In Accounts Receivable | -12.36M | -598K | -1.14M | -6.97M | -13.36M |
Change In Inventories | -1.12M | 2.38M | -1.42M | 1.18M | -2.84M |
Change In Accounts Payable | 4.27M | -4.06M | -3.84M | 2.81M | 19.88M |
Change in Other Net Operating Assets | 5.13M | 9.34M | 20M | 48.65M | 62.12M |
Cash from Operations | -60.42M | -31.46M | -28.66M | -21.26M | -20.71M |
Capital Expenditure | -584K | -25K | - | -7K | -30K |
Cash Acquisitions | -17.04M | - | - | - | - |
Sale (Purchase) of Intangible assets | - | - | - | -2.06M | -300K |
Cash from Investing | -17.62M | -25K | - | -2.07M | -330K |
Short Term Debt Issued, Total | - | 18.4M | 47.85M | 51.9M | - |
Long-Term Debt Issued, Total | 21.63M | 21.31M | 62.53M | 72.36M | 110M |
Total Debt Issued | 21.63M | 39.71M | 110M | 124M | 110M |
Long-Term Debt Repaid, Total | -5.85M | -58.93M | -82.22M | -104M | -84.63M |
Total Debt Repaid | -5.85M | -58.93M | -82.22M | -104M | -84.63M |
Issuance of Common Stock | - | 50K | - | 96K | 36.59M |
Repurchase of Common Stock | - | - | - | - | -10M |
Other Financing Activities, Total | - | - | - | 426K | -28.74M |
Cash from Financing | 15.78M | -19.17M | 28.16M | 21.17M | 23.58M |
Net Change in Cash | -62.27M | -50.66M | -501K | -2.15M | 2.54M |
Supplemental Items | |||||
Cash Interest Paid | - | - | - | - | 1.43M |
Levered Free Cash Flow | - | - | 48.88M | -103M | 33.57M |
Unlevered Free Cash Flow | - | - | 48.32M | -100M | 34.18M |
Change In Net Working Capital | - | - | -61.12M | 76.02M | -81.66M |
Net Debt Issued / Repaid | 15.78M | -19.22M | 28.16M | 20.65M | 25.73M |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
Profitability | |||||
Return on Assets | - | - | -28.1 | -38.49 | -70.16 |
Return on Total Capital | - | - | 62.06 | 201.05 | 1.93K |
Return On Equity % | - | - | 48.38 | 24.9 | 167.27 |
Return on Common Equity | - | - | 48.38 | 24.9 | 244.29 |
Margin Analysis | |||||
Gross Profit Margin % | 72.41 | 90.88 | 88.4 | 71.61 | 66.45 |
SG&A Margin | 307.59 | 182.39 | 161.52 | 170.62 | 255.95 |
EBITDA Margin % | -283.57 | -133.62 | -102.37 | -122.71 | -216.68 |
EBITA Margin % | -283.75 | -133.79 | -102.5 | -122.82 | -216.77 |
EBIT Margin % | -301.4 | -149.65 | -114.44 | -133.13 | -225.55 |
Income From Continuing Operations Margin % | -849.11 | -201.69 | -282.35 | -61.43 | -244.59 |
Net Income Margin % | -849.11 | -201.69 | -282.35 | -61.43 | -244.59 |
Net Avail. For Common Margin % | -849.11 | -201.69 | -282.35 | -61.43 | -357.22 |
Normalized Net Income Margin | -306.93 | -126.2 | -151.59 | -85.44 | -143.24 |
Levered Free Cash Flow Margin | - | - | 156.08 | -271.75 | 71.83 |
Unlevered Free Cash Flow Margin | - | - | 154.31 | -264.23 | 73.12 |
Asset Turnover | |||||
Asset Turnover | - | - | 0.39 | 0.46 | 0.5 |
Fixed Assets Turnover | - | - | 13.53 | 18.96 | 16.79 |
Receivables Turnover (Average Receivables) | - | - | 2.29 | 2.14 | 1.67 |
Inventory Turnover (Average Inventory) | - | - | 1.96 | 5.48 | 5.61 |
Short Term Liquidity | |||||
Current Ratio | - | 0.29 | 0.14 | 0.66 | 0.19 |
Quick Ratio | - | 0.23 | 0.11 | 0.52 | 0.15 |
Operating Cash Flow to Current Liabilities | - | -0.4 | -0.17 | -0.47 | -0.08 |
Days Sales Outstanding (Average Receivables) | - | - | 159.64 | 170.36 | 217.99 |
Days Outstanding Inventory (Average Inventory) | - | - | 186.17 | 66.6 | 65.08 |
Average Days Payable Outstanding | - | - | 448.17 | 241.75 | 486.92 |
Cash Conversion Cycle (Average Days) | - | - | -102.37 | -4.79 | -203.85 |
Long Term Solvency | |||||
Total Debt/Equity | - | -97.84 | -69.12 | 3.89 | -74.28 |
Total Debt / Total Capital | - | -4.54K | -223.85 | 3.75 | -288.84 |
LT Debt/Equity | - | -77.15 | -43.19 | 1.84 | -11.15 |
Long-Term Debt / Total Capital | - | -3.58K | -139.86 | 1.77 | -43.34 |
Total Liabilities / Total Assets | - | 273.84 | 387.27 | 58.12 | 270.7 |
EBIT / Interest Expense | -3.75 | -2.69 | -3.05 | -5.27 | -98.72 |
EBITDA / Interest Expense | -3.53 | -2.33 | -2.67 | -4.81 | -93.81 |
(EBITDA - Capex) / Interest Expense | -3.57 | -2.33 | -2.67 | -4.81 | -93.83 |
Total Debt / EBITDA | - | -4.53 | -4.92 | -0.03 | -1.28 |
Net Debt / EBITDA | - | -4.38 | -4.78 | 0.02 | -1.24 |
Total Debt / (EBITDA - Capex) | - | -4.53 | -4.92 | -0.03 | -1.28 |
Net Debt / (EBITDA - Capex) | - | -4.37 | -4.78 | 0.02 | -1.24 |
Growth Over Prior Year | |||||
Total Revenues, 1 Yr. Growth % | - | 12.01 | 32.92 | 21.45 | 22.9 |
Gross Profit, 1 Yr. Growth % | - | 40.58 | 29.29 | -1.61 | 14.04 |
EBITDA, 1 Yr. Growth % | - | -47.22 | 1.84 | 45.58 | 117.01 |
EBITA, 1 Yr. Growth % | - | -47.19 | 1.84 | 45.52 | 116.91 |
EBIT, 1 Yr. Growth % | - | -44.38 | 1.64 | 41.29 | 108.22 |
Earnings From Cont. Operations, 1 Yr. Growth % | - | -73.39 | 86.08 | -73.58 | 389.35 |
Net Income, 1 Yr. Growth % | - | -73.39 | 86.08 | -73.58 | 389.35 |
Normalized Net Income, 1 Yr. Growth % | - | -53.94 | 59.67 | -31.55 | 106.04 |
Diluted EPS Before Extra, 1 Yr. Growth % | - | -74.71 | 86.86 | -74.02 | 636.22 |
Accounts Receivable, 1 Yr. Growth % | - | - | 8.7 | 48.84 | 62.92 |
Inventory, 1 Yr. Growth % | - | - | 123.76 | -46.21 | 205.81 |
Net Property, Plant and Equip., 1 Yr. Growth % | - | - | -16.38 | -9.72 | 92.59 |
Total Assets, 1 Yr. Growth % | - | - | -4.38 | 11.03 | 17.08 |
Tangible Book Value, 1 Yr. Growth % | - | - | 39.68 | -93.54 | 1.15K |
Common Equity, 1 Yr. Growth % | - | - | 58.01 | -116.19 | -577.25 |
Cash From Operations, 1 Yr. Growth % | - | -47.93 | -8.89 | -25.84 | -2.59 |
Capital Expenditures, 1 Yr. Growth % | - | -95.72 | - | - | 328.57 |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | - | -311.45 | -132.48 |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | - | -307.96 | -134.01 |
Compound Annual Growth Rate Over Two Years | |||||
Total Revenues, 2 Yr. CAGR % | - | - | 22.02 | 27.06 | 22.17 |
Gross Profit, 2 Yr. CAGR % | - | - | 34.82 | 12.79 | 5.93 |
EBITDA, 2 Yr. CAGR % | - | - | -26.69 | 21.76 | 77.75 |
EBITA, 2 Yr. CAGR % | - | - | -26.66 | 21.74 | 77.67 |
EBIT, 2 Yr. CAGR % | - | - | -24.81 | 19.84 | 71.52 |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | - | -29.64 | -29.88 | 13.71 |
Net Income, 2 Yr. CAGR % | - | - | -29.64 | -29.88 | 13.71 |
Normalized Net Income, 2 Yr. CAGR % | - | - | -14.25 | 4.54 | 18.76 |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | -31.26 | -30.46 | 38.3 |
Accounts Receivable, 2 Yr. CAGR % | - | - | - | 27.2 | 55.72 |
Inventory, 2 Yr. CAGR % | - | - | - | 9.7 | 28.25 |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | - | -13.12 | 31.86 |
Total Assets, 2 Yr. CAGR % | - | - | - | 3.04 | 14.02 |
Tangible Book Value, 2 Yr. CAGR % | - | - | - | -69.96 | -10.16 |
Common Equity, 2 Yr. CAGR % | - | - | - | -49.43 | -12.11 |
Cash From Operations, 2 Yr. CAGR % | - | - | -31.12 | -17.8 | -15.01 |
Capital Expenditures, 2 Yr. CAGR % | - | - | - | -47.08 | - |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | - | - | -17.12 |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | - | - | -15.9 |
Compound Annual Growth Rate Over Three Years | |||||
Total Revenues, 3 Yr. CAGR % | - | - | - | 21.83 | 25.66 |
Gross Profit, 3 Yr. CAGR % | - | - | - | 21.38 | 13.2 |
EBITDA, 3 Yr. CAGR % | - | - | - | -7.85 | 47.63 |
EBITA, 3 Yr. CAGR % | - | - | - | -7.84 | 47.59 |
EBIT, 3 Yr. CAGR % | - | - | - | -7.22 | 44.07 |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | - | -49.24 | 34 |
Net Income, 3 Yr. CAGR % | - | - | - | -49.24 | 34 |
Normalized Net Income, 3 Yr. CAGR % | - | - | - | -20.45 | 31.07 |
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | - | -43.25 | 52.69 |
Accounts Receivable, 3 Yr. CAGR % | - | - | - | - | 38.13 |
Inventory, 3 Yr. CAGR % | - | - | - | - | 54.39 |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | - | - | 13.28 |
Total Assets, 3 Yr. CAGR % | - | - | - | - | 7.52 |
Tangible Book Value, 3 Yr. CAGR % | - | - | - | - | 4.08 |
Common Equity, 3 Yr. CAGR % | - | - | - | - | 6.87 |
Cash From Operations, 3 Yr. CAGR % | - | - | - | -29.4 | -13.01 |
Capital Expenditures, 3 Yr. CAGR % | - | - | - | -77.11 | 6.27 |